Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11—first estimates for clinical translation

por Kaloudi, Aikaterini, Nock, Berthold A., Lymperis, Emmanouil, Valkema, Roelf, Krenning, Eric P., de Jong, Marion, Maina, Theodosia
Publicado 2016

Comparing Gly(11)/dAla(11)-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the (111)In-SB3/(111)In-SB4 Radiotracer Pair

por Lymperis, Emmanouil, Kaloudi, Aikaterini, Kanellopoulos, Panagiotis, de Jong, Marion, Krenning, Eric P., Nock, Berthold A., Maina, Theodosia
Publicado 2019

[(99m)Tc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models

por Kanellopoulos, Panagiotis, Lymperis, Emmanouil, Kaloudi, Aikaterini, de Jong, Marion, Krenning, Eric P., Nock, Berthold A., Maina, Theodosia
Publicado 2020

NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [(67)Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice

por Kaloudi, Aikaterini, Lymperis, Emmanouil, Giarika, Athina, Dalm, Simone, Orlandi, Francesca, Barbato, Donato, Tedesco, Mattia, Maina, Theodosia, de Jong, Marion, Nock, Berthold A.
Publicado 2017

Localization of (99m)Tc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses

por Kaloudi, Aikaterini, Lymperis, Emmanouil, Kanellopoulos, Panagiotis, Waser, Beatrice, de Jong, Marion, Krenning, Eric P., Reubi, Jean Claude, Nock, Berthold A., Maina, Theodosia
Publicado 2019